ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

DeVita To Discuss NCI Plans for CCOPs at ACCC Meetings

January 17, 1986

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003

NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects

October 8, 1982

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

Science Policy: NCAB Opposes Law Making Data Available Under FOIA; Individuals Encouraged To Send comments To OMB

March 19, 1999